Field Application Specialist
About the job
- English is mandatory.
- A minimum Bachelor of Science degree in Biology, Molecular Biology, or a related field is required; relevant professional experience may be considered instead.
- Previous next-generation sequencing and liquid handling experience is preferred.
- Provide first- and second-level application support for molecular and genetic testing products, including polymerase chain reaction, Sanger sequencing, and next-generation sequencing.
- Support affiliates and distributors.
- Conduct product and application training.
- Manage product updates and complaints.
- Gather market intelligence.
- Collaborate with internal teams.
- Contribute to customer relationship management.
- Ensure efficient post-marketing surveillance.
- Travel up to 80% internationally to client sites.
- Knowledge of additional languages.
- Previous next-generation sequencing and liquid handling experience.
About the company
Advanced Biological Laboratories provides software, assays, and IT solutions for infectious disease diagnostics and clinical genotyping. It supports molecular detection, sequencing-based genotyping, and data analysis for pathogens such as HIV, SARS-CoV-2, HBV, HCV, and tuberculosis, compatible with Sanger and Next Generation Sequencing. The company earns recurring revenue by offering end-to-end solutions for labs and researchers, including CRO services and assay manufacturing through acquisitions. Its aim is to deliver integrated tools that streamline detection, drug-resistance analysis, and data-driven patient management in infectious diseases.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Luxembourg, Luxembourg
Founded
2000
Simplify's Take
What believers are saying
- ABL Diagnostics posted H1 2026 revenue of €5.415 million, up 90%.
- July 2026 UltraGene Viral Meningitis and Respiratory Pathogens 21 expanded the menu.
- ABL selected by Évry Commercial Court on July 22, 2026, to acquire TEXCELL operations.
What critics are saying
- ABL abandoned ProPhase Labs reverse merger on February 19, 2026, signaling deal fragility.
- Main shareholder sold ABL Diagnostics blocks again on June 5 and July 22, 2026.
- IVDR deadlines threaten legacy UltraGene and DeepChek products if certification slips past 2028-2029.
What makes Advanced Biological Laboratories unique
- ABL controls assays, sequencing software, and manufacturing across infectious-disease workflows.
- Its Fast Track Diagnostics rights and DeepChek portfolio create recurring laboratory revenue.
- ABL uses CE-IVD devices and ISO 13485 manufacturing to ship globally.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Flexible Work Hours
- Professional Development Budget